Shield Therapeutics plc (AIM:STX)

London · Delayed Price · Currency is GBP · Price in GBX

3.950

-0.450 (-10.23%)

Jul 31, 2026, 5:06 PM GMT

Shield Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	42	105	28	52	18	96
Market Cap Growth	-9.97%	273.97%	-46.37%	186.64%	-80.96%	29.05%
Enterprise Value	55.96	118.95	43.94	57.39	21.09	84.13
Last Close Price	0.04	0.10	0.03	0.07	0.07	0.45

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	113.42	113.42	113.42	113.42	113.42
PS Ratio	1.14	2.85	1.10	5.10	4.02	63.24
PB Ratio	-3.77	-9.38	-26.80	4.44	3.38	2.35
P/TBV Ratio	-	-	-	-	-	4.75

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1.52	3.22	1.71	5.58	4.64	55.39

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-2.00	-2.00	-19.87	1.33	1.02	0
Net Debt / Equity Ratio	-1.23	-1.23	-15.07	0.42	0.52	-0.29
Net Debt / EBITDA Ratio	-3.96	-2.07	-0.92	-0.21	-0.07	0.66
Net Debt / FCF Ratio	-5.44	-5.44	-2.92	-0.17	-0.15	0.64
Asset Turnover	0.81	0.81	0.61	0.35	0.13	0.04
Inventory Turnover	3.58	3.58	3.89	3.65	1.53	0.65
Quick Ratio	0.72	0.72	0.97	2.00	0.77	4.45
Current Ratio	0.90	0.90	1.16	2.28	0.95	5.11
Return on Equity (ROE)	215.38%	215.38%	-396.36%	-308.60%	-160.88%	-381.19%
Return on Assets (ROA)	-9.72%	-16.87%	-44.06%	-85.44%	-116.04%	-51.97%
Return on Invested Capital (ROIC)	-39.61%	-51.87%	-101.38%	-206.12%	-204.28%	-67.29%
Return on Capital Employed (ROCE)	-29.02%	-50.36%	-76.34%	-128.27%	-143.91%	-56.72%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-33.81%	-33.81%	-8.33%	-209.85%	-14.08%	-74.36%
Total Shareholder Return	-33.81%	-33.81%	-8.33%	-209.85%	-14.08%	-74.36%